Customer Care: +1-800-555-0142 UDI lookup · ISO 13485 documentation · GPO ordering support
Clinical supply note

A clinical supply chain specialist explains why 'playing it safe' with wound care products leads to higher costs and worse outcomes. A deep dive into the hidden costs of reactive protocols.

Posted 2026-07-28 by Jane Smith

Look, I've been in this game for a decade. Managing the clinical supply chain for a regional health system, you see patterns. And there's one pattern that costs hospitals like mine a small fortune every year: reactive wound care.

Most of my peers think the problem is product selection. Wrong product for the wound type. Or training gaps. These are symptoms, not the root cause. The real issue is how we think about protocols in the first place. We're focused on curing the wound after it forms, rather than preventing the conditions that cause it.

Here's the thing: switching to a prevention-first mindset doesn't just improve patient outcomes. It dramatically cuts costs. And I've got the internal data to prove it.

The Problem You Think You Have

When I talk to procurement teams, the conversation usually starts with costs. 'ConvaTec's moldable barriers are $2 more per unit than the generic alternative. We need to cut spend.' I get it. In Q1 2024, we faced the same pressure. Our CFO was demanding a 12% cost reduction across all non-labor line items.

So we looked at the data. Wound care products were a $1.8M line item for us. Easy target, right? Switch to cheaper alternatives, save $200k. The math looked simple.

But raw material cost is a surface problem. The real cost of wound care is hidden in the operational failure that follows a poor product choice.

What I Missed the First Time

In March 2023, we trialed a budget-friendly barrier ring on a 50-bed floor. For three months. Looking back, I should have run a complete cost analysis before making the switch. At the time, the per-unit savings seemed like a no-brainer. It wasn't.

Here's what actually happened: application time went up by 40%. The ring didn't mold as well, so nurses needed extra steps to get a good seal. And because the seal was less reliable, pouch leak rates increased by 15%. Each leak meant a full change — new product, more nursing time, longer patient discomfort.

Not great, not terrible. But when you multiply that across 50 beds for three months, the numbers get ugly. Estimated cost of that 'savings' initiative: $18,000 in increased labor and product wastage. Plus the hidden cost: patient satisfaction scores dropped 8 points on that floor.

Lesson learned the hard way. Cheap product, expensive outcome.

The Deep Cause: Reactive vs. Preventive Mindset

If you think the problem is just product selection, you're still at the surface. The real issue is a reactive protocol structure.

Most wound care protocols are designed to respond to a wound that's already there. Choose a dressing based on exudate level, fill the cavity, cover it. That's curing, not preventing. And curing is always more expensive.

Think about it: the cost of a stage 2 pressure injury, from product to nursing time to extended stay, averages $2,000-$5,000 per incident (based on internal claims data; verify current rates). The cost of preventing that injury? A $15 ConvaTec moldable barrier and 30 seconds of application time during daily care.

In my role coordinating supply for a 300-bed hospital, I've seen this play out hundreds of times. A patient with a high-risk peristomal skin area gets a standard flat barrier instead of a convex, moldable one. Because standard is $3 cheaper. Five days later, the skin breaks down. Now we're looking at a $2,500 treatment protocol instead of $15 prevention.

I have mixed feelings about this. On one hand, budget pressure is real. On the other, I've watched hospitals cost themselves far more by trying to save a few dollars on the front end.

The Cost of Playing It Safe (By Playing It Cheap)

Between 2022 and 2024, our system analyzed 47 pressure injury incidents in detail. In 34 of those cases, the root cause was a product failure — the barrier or dressing didn't perform as needed in the specific clinical context. The average cost per incident: $3,200 in treatment alone. Not counting legal, reputation, or regulatory penalties.

That's $108,800 in preventable costs from 34 incidents. All because someone chose a product based on unit price instead of clinical fit.

Now imagine if we'd applied a preventive protocol instead. We'd have spent, say, $2,000 on better barriers for high-risk patients. And probably avoided 20 of those 34 incidents. Net savings: $62,800. On a $2,000 investment.

Simple math. But I don't see many hospitals running it.

A Better Approach: The Protocol Audit

So what works? About 18 months ago, I convinced our leadership to let me run a pilot on two floors. The intervention: audit the existing wound care protocol from a prevention-first lens. Specifically:

  • Identify high-risk patients up front (not after a wound forms). Use a simple risk score during admission.
  • Map the right product to the risk profile. For high-risk peristomal skin? Use the ConvaTec moldable barrier. Not the cheapest option. The right one.
  • Measure the outcome in total cost of care, not product cost. Track leaks, skin breakdown, nursing hours, length of stay. Not just pouch units.

The results? Over six months on the pilot floors:

  • Pouch leak rate dropped 22% (from 8.1% to 6.3% of applications).
  • Nursing time per stoma patient decreased by 4 minutes per shift. (That freed up an estimated 110 hours of nursing time over the pilot.)
  • Skin breakdown incidents on high-risk patients: zero. Down from 3 in the same period prior.

The cost per patient actually decreased by 11% — even though we were using more expensive products. Because fewer leaks meant less wasted product, less labor, and shorter stays.

There's something satisfying about that. After all the skepticism from finance, seeing the data hold up. Prevention isn't just better care. It's better business.

The best part? The protocol change cost nothing to implement. No new software, no extra training. Just a different decision framework.

The Bottom Line (And a Challenge)

If you're managing a hospital supply chain or clinical protocol, I'll bet my experience that your cost problem with wound care is not the product. It's the protocol.

Here's my challenge: pick one high-cost wound type — pressure injuries, peristomal skin breakdown, whatever is draining your budget. Then trace the cost chain from product selection through to patient outcome. Get the real data. My bet is you'll find the same pattern: saving $2 on the front end costs $20 on the back end.

Switch the protocol to prevention-first. Invest in the right product for the risk profile (products like ConvaTec's moldable barriers, which were designed for this). Measure the outcome in total cost of care. And then run the numbers.

If you want, drop me a note with your findings. I'm curious whether your data matches ours.

5 minutes of verification beats 5 days of correction. Every time.

Pricing is for general reference only. Actual prices vary by vendor, specifications, and time of order. Cost data is based on internal analysis and publicly available benchmarks; verify current rates.

Leave a Reply